Bioneer Corporation (KOSDAQ:064550)
South Korea · Delayed Price · Currency is KRW 11,000
+2,210 (25.14%)
Sep 1, 2026, 3:30 PM KST
Bioneer Market Cap
Bioneer has a market cap or net worth of 226.87 billion as of September 1, 2026. Its market cap has decreased by -37.48% in one year.
Market Cap
226.87B
Enterprise Value
260.74B
Revenue
345.88B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,000.00
ChartMarket Cap Chart
Since December 29, 2005, Bioneer's market cap has increased from 157.77B to 226.87B, an increase of 43.80%. That is a compound annual growth rate of 1.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 226.87B | -31.06% |
| Dec 30, 2025 | 329.08B | -32.36% |
| Dec 30, 2024 | 486.52B | -43.39% |
| Dec 28, 2023 | 859.48B | 13.27% |
| Dec 29, 2022 | 758.82B | -39.51% |
| Dec 30, 2021 | 1.25T | 181.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Proteina | 396.16B |
| SillaJen | 360.24B |
| MEDIPOST | 350.99B |
| Genomictree | 288.19B |
| NeoImmuneTech | 248.16B |
| GC Cell | 202.72B |
| HLB Therapeutics | 196.24B |
| Anterogen.Co.,Ltd. | 148.59B |